Epizyme Operating Expenses | EPZM

Annual Operating Expenses Epizyme

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
-	236 M	201 M	150 M	147 M	120 M	135 M	96.5 M	71.6 M	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
236 M	71.6 M	145 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Halozyme Therapeutics HALO	218 M	$ 108.31	2.73 %	$ 13 B	USA
Hutchison China MediTech Limited HCM	236 M	$ 14.31	0.77 %	$ 12.3 B	China
Harmony Biosciences Holdings HRMY	462 M	$ 39.92	0.71 %	$ 2.3 B	USA
Heron Therapeutics HRTX	281 M	$ 0.37	6.44 %	$ 61.7 M	USA
iBio IBIO	35.2 M	$ 1.12	0.89 %	$ 117 M	USA
ImmuCell Corporation ICCC	9.8 M	$ 9.75	1.56 %	$ 88 M	USA
IDEAYA Biosciences IDYA	378 M	$ 38.06	1.87 %	$ 3.37 B	USA
InflaRx N.V. IFRX	52.4 M	$ 1.68	0.58 %	$ 113 M	Germany
Immutep Limited IMMP	16.6 M	$ 4.27	0.46 %	$ 6.22 B	Australia
Immunome IMNM	231 M	$ 21.17	1.29 %	$ 1.85 B	USA
Immunic IMUX	103 M	$ 8.07	1.38 %	$ 1.26 B	USA
Immunovant IMVT	533 M	$ 33.25	0.18 %	$ 6.07 B	USA
Innate Pharma S.A. IPHA	63 M	$ 1.58	1.28 %	$ 142 M	France
Incyte Corporation INCY	1.62 B	$ 114.13	0.06 %	$ 22.3 B	USA
InMed Pharmaceuticals INM	11.6 M	$ 1.33	0.01 %	$ 5.54 M	Canada
INmune Bio INMB	47.4 M	$ 1.94	0.52 %	$ 48 M	USA
Inovio Pharmaceuticals INO	86.9 M	$ 1.15	2.05 %	$ 53.9 M	USA
Insmed Incorporated INSM	348 M	$ 103.83	2.33 %	$ 20.7 B	USA
Innoviva INVA	144 M	$ 20.64	0.68 %	$ 1.39 B	USA
Iovance Biotherapeutics IOVA	399 M	$ 14.15	0.63 %	$ 5.06 M	USA
Ironwood Pharmaceuticals IRWD	287 M	$ 3.65	0.27 %	$ 591 M	USA
Inventiva S.A. IVA	36.2 M	$ 3.48	2.89 %	$ 208 M	France
Jaguar Health JAGX	36 M	$ 4.73	29.23 %	$ 11 M	USA
Jazz Pharmaceuticals plc JAZZ	1.39 B	$ 236.04	0.16 %	$ 14.4 B	Irlanda
Johnson & Johnson JNJ	37.3 B	$ 252.93	0.03 %	$ 609 B	USA
Kala Pharmaceuticals KALA	39.2 M	$ 0.36	0.86 %	$ 2.93 M	USA
Kiniksa Pharmaceuticals, Ltd. KNSA	170 M	$ 76.31	0.69 %	$ 5.66 B	USA
Kodiak Sciences KOD	234 M	$ 93.81	0.32 %	$ 4.99 B	USA
Karyopharm Therapeutics KPTI	237 M	$ 0.67	1.51 %	$ 7.33 K	USA
Keros Therapeutics KROS	176 M	$ 11.52	1.41 %	$ 429 M	USA
Krystal Biotech KRYS	228 M	$ 334.85	3.9 %	$ 9.69 B	USA
Kura Oncology KURA	371 M	$ 10.62	0.09 %	$ 931 M	USA
Kymera Therapeutics KYMR	389 M	$ 109.85	2.29 %	$ 9.28 B	USA
Kazia Therapeutics Limited KZIA	8.82 M	$ 9.35	0.86 %	$ 143 M	Australia
Lineage Cell Therapeutics LCTX	8.19 M	$ 0.93	2.73 %	$ 214 M	USA
Legend Biotech Corporation LEGN	193 M	$ 18.77	1.1 %	$ 6.92 B	USA
Ligand Pharmaceuticals Incorporated LGND	115 M	$ 306.77	1.26 %	$ 5.93 B	USA
Longeveron LGVN	24.1 M	$ 2.51	0.39 %	$ 44.1 B	USA
Eli Lilly and Company LLY	11.8 B	$ 1 143.12	0.02 %	$ 1.03 T	USA
Lipocine LPCN	12.3 M	$ 2.07	0.98 %	$ 11.3 M	USA
Liquidia Corporation LQDA	59.6	$ 27.64	2.32 %	$ 2.38 B	USA
Larimar Therapeutics LRMR	172 M	$ 2.86	1.75 %	$ 238 M	USA
Lantern Pharma LTRN	18 M	$ 0.94	9.3 %	$ 10.2 M	USA
Lexicon Pharmaceuticals LXRX	101 M	$ 1.74	0.82 %	$ 632 M	USA
Mustang Bio MBIO	2.43 M	$ 0.46	1.16 %	$ 2.26 M	USA
Moleculin Biotech MBRX	25.1 M	$ 0.48	0.42 %	$ 569 K	USA
Seres Therapeutics MCRB	94.8 M	$ 2.85	0.34 %	$ 25.2 M	USA
Madrigal Pharmaceuticals MDGL	1.26 B	$ 493.62	0.1 %	$ 11.1 B	USA